Insider Transactions Reported by 21 Insiders of Prime Medicine, Inc.

Symbol
PRME on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Prime Medicine, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
2019 GP L.L.C. GV 10%+ Owner $177,594,643 20 Jun 2023
FMR LLC Other* $126,699,612 24 Oct 2022
ROBERT NELSEN Director, 10%+ Owner $73,946,120 +$9,999,990 +16% 01 Aug 2025
ARCH Venture Partners X, LLC 10%+ Owner $73,876,172 +$9,999,990 +16% 01 Aug 2025
ARCH Venture Partners XII, LLC 10%+ Owner $73,876,172 +$9,999,990 +16% 01 Aug 2025
David R. Liu 10%+ Owner $50,920,145 +$163,017 +0.32% 30 Jun 2025
2023 GP L.L.C. GV Member of 10% Group $20,000,000 20 Feb 2024
Keith Michael Gottesdiener Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director $19,020,856 08 May 2025
2021 GP L.L.C. GV 10%+ Owner $10,766,052 +$4,950,000 +85% 01 Aug 2025
Allan Reine Chief Executive Officer, Director $147,150 +$147,150 26 Feb 2026
ANN L. LEE Chief Technical Officer $112,999 +$113,000 23 Feb 2026
Richard Brudnick Chief Business Officer $23,790 +$23,790 20 May 2025
Jeremy Duffield Chief Scientific Officer 27 Feb 2025
Meredith Goldwasser SVP, Strategy & Corporate Ops. 27 Feb 2025
David P. Schenkein Director 01 Aug 2025
Jeffrey D. Marrazzo Director 01 Aug 2025
Michael Aaron Kelly Director 01 Aug 2025
I. Foster Cheek Director 01 Aug 2025
Carman Alenson SVP, Finance and Chief Accounting Officer 23 Feb 2026
Wendy Chung Director 01 Aug 2025
Thomas Cahill Director 01 Aug 2025

Recent Insider Transactions by Companies or Individuals for Prime Medicine, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.